nodes	percent_of_prediction	percent_of_DWPC	metapath
Desloratadine—CYP1A2—Clobetasol propionate—psoriasis	0.124	0.17	CbGbCtD
Desloratadine—CYP1A2—Methoxsalen—psoriasis	0.0654	0.0894	CbGbCtD
Desloratadine—CYP2D6—Hydroxyurea—psoriasis	0.0589	0.0805	CbGbCtD
Desloratadine—CYP2C19—Cholecalciferol—psoriasis	0.0469	0.0642	CbGbCtD
Desloratadine—CYP2C9—Cholecalciferol—psoriasis	0.039	0.0534	CbGbCtD
Desloratadine—CYP2D6—Cholecalciferol—psoriasis	0.0357	0.0488	CbGbCtD
Desloratadine—ABCB1—Mycophenolate mofetil—psoriasis	0.0328	0.0449	CbGbCtD
Desloratadine—CYP2C19—Prednisone—psoriasis	0.0325	0.0445	CbGbCtD
Desloratadine—CYP2C19—Cyclosporine—psoriasis	0.0308	0.0422	CbGbCtD
Desloratadine—ABCB1—Betamethasone—psoriasis	0.0282	0.0385	CbGbCtD
Desloratadine—ABCB1—Prednisolone—psoriasis	0.0278	0.038	CbGbCtD
Desloratadine—ABCB1—Hydrocortisone—psoriasis	0.0263	0.036	CbGbCtD
Desloratadine—ABCB1—Prednisone—psoriasis	0.0262	0.0359	CbGbCtD
Desloratadine—CYP2C9—Cyclosporine—psoriasis	0.0256	0.0351	CbGbCtD
Desloratadine—ABCB1—Cyclosporine—psoriasis	0.0249	0.034	CbGbCtD
Desloratadine—CYP2D6—Cyclosporine—psoriasis	0.0234	0.0321	CbGbCtD
Desloratadine—CYP2C19—Dexamethasone—psoriasis	0.0203	0.0278	CbGbCtD
Desloratadine—CYP2C9—Dexamethasone—psoriasis	0.0169	0.0231	CbGbCtD
Desloratadine—ABCB1—Dexamethasone—psoriasis	0.0164	0.0224	CbGbCtD
Desloratadine—CYP2D6—Dexamethasone—psoriasis	0.0154	0.0211	CbGbCtD
Desloratadine—ABCB1—Methotrexate—psoriasis	0.0132	0.018	CbGbCtD
Desloratadine—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.00116	0.0691	CbGpPWpGaD
Desloratadine—CYP2D6—CYP2E1 reactions—CYP2S1—psoriasis	0.00107	0.0636	CbGpPWpGaD
Desloratadine—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.00106	0.063	CbGpPWpGaD
Desloratadine—CYP2D6—Miscellaneous substrates—CYP2S1—psoriasis	0.000998	0.0593	CbGpPWpGaD
Desloratadine—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.000721	0.0429	CbGpPWpGaD
Desloratadine—CYP2D6—Xenobiotics—CYP2S1—psoriasis	0.000663	0.0394	CbGpPWpGaD
Desloratadine—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.000658	0.0391	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—IL22—psoriasis	0.000565	0.0336	CbGpPWpGaD
Desloratadine—CYP1A2—Xenobiotics—CYP2S1—psoriasis	0.000562	0.0334	CbGpPWpGaD
Desloratadine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.0003	0.0178	CbGpPWpGaD
Desloratadine—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000296	0.0176	CbGpPWpGaD
Desloratadine—Angioedema—Triamcinolone—psoriasis	0.000285	0.00113	CcSEcCtD
Desloratadine—Rash—Hydroxyurea—psoriasis	0.000283	0.00112	CcSEcCtD
Desloratadine—Erythema—Betamethasone—psoriasis	0.000283	0.00112	CcSEcCtD
Desloratadine—Erythema—Dexamethasone—psoriasis	0.000283	0.00112	CcSEcCtD
Desloratadine—Anorexia—Mycophenolate mofetil—psoriasis	0.000283	0.00112	CcSEcCtD
Desloratadine—Dermatitis—Hydroxyurea—psoriasis	0.000283	0.00112	CcSEcCtD
Desloratadine—Myalgia—Hydrocortisone—psoriasis	0.000282	0.00112	CcSEcCtD
Desloratadine—Hallucination—Prednisone—psoriasis	0.000282	0.00112	CcSEcCtD
Desloratadine—Headache—Hydroxyurea—psoriasis	0.000281	0.00112	CcSEcCtD
Desloratadine—Connective tissue disorder—Prednisone—psoriasis	0.000278	0.0011	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000277	0.0011	CcSEcCtD
Desloratadine—Oedema—Prednisolone—psoriasis	0.000277	0.0011	CcSEcCtD
Desloratadine—Anaphylactic shock—Prednisolone—psoriasis	0.000277	0.0011	CcSEcCtD
Desloratadine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000275	0.0164	CbGpPWpGaD
Desloratadine—Insomnia—Cyclosporine—psoriasis	0.000275	0.00109	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Methotrexate—psoriasis	0.000275	0.00109	CcSEcCtD
Desloratadine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000273	0.0162	CbGpPWpGaD
Desloratadine—Cough—Triamcinolone—psoriasis	0.000272	0.00108	CcSEcCtD
Desloratadine—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000272	0.0162	CbGpPWpGaD
Desloratadine—Dyspnoea—Cyclosporine—psoriasis	0.000271	0.00108	CcSEcCtD
Desloratadine—Somnolence—Cyclosporine—psoriasis	0.00027	0.00107	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.00027	0.00107	CcSEcCtD
Desloratadine—Anaphylactic shock—Hydrocortisone—psoriasis	0.00027	0.00107	CcSEcCtD
Desloratadine—Oedema—Hydrocortisone—psoriasis	0.00027	0.00107	CcSEcCtD
Desloratadine—Convulsion—Triamcinolone—psoriasis	0.00027	0.00107	CcSEcCtD
Desloratadine—Tachycardia—Prednisolone—psoriasis	0.00027	0.00107	CcSEcCtD
Desloratadine—Asthenia—Mycophenolic acid—psoriasis	0.00027	0.00107	CcSEcCtD
Desloratadine—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00027	0.016	CbGpPWpGaD
Desloratadine—Infection—Hydrocortisone—psoriasis	0.000269	0.00107	CcSEcCtD
Desloratadine—Insomnia—Mycophenolate mofetil—psoriasis	0.000268	0.00106	CcSEcCtD
Desloratadine—Dyspepsia—Cyclosporine—psoriasis	0.000268	0.00106	CcSEcCtD
Desloratadine—Nausea—Hydroxyurea—psoriasis	0.000267	0.00106	CcSEcCtD
Desloratadine—Pruritus—Mycophenolic acid—psoriasis	0.000266	0.00106	CcSEcCtD
Desloratadine—Myalgia—Triamcinolone—psoriasis	0.000265	0.00105	CcSEcCtD
Desloratadine—Nervous system disorder—Hydrocortisone—psoriasis	0.000265	0.00105	CcSEcCtD
Desloratadine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000264	0.00105	CcSEcCtD
Desloratadine—Decreased appetite—Cyclosporine—psoriasis	0.000264	0.00105	CcSEcCtD
Desloratadine—Tachycardia—Hydrocortisone—psoriasis	0.000264	0.00105	CcSEcCtD
Desloratadine—Somnolence—Mycophenolate mofetil—psoriasis	0.000264	0.00105	CcSEcCtD
Desloratadine—Infestation—Methotrexate—psoriasis	0.000264	0.00105	CcSEcCtD
Desloratadine—Infestation NOS—Methotrexate—psoriasis	0.000264	0.00105	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000263	0.00104	CcSEcCtD
Desloratadine—Fatigue—Cyclosporine—psoriasis	0.000262	0.00104	CcSEcCtD
Desloratadine—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000261	0.00104	CcSEcCtD
Desloratadine—Dry mouth—Triamcinolone—psoriasis	0.00026	0.00103	CcSEcCtD
Desloratadine—Angioedema—Betamethasone—psoriasis	0.000259	0.00103	CcSEcCtD
Desloratadine—Angioedema—Dexamethasone—psoriasis	0.000259	0.00103	CcSEcCtD
Desloratadine—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000258	0.00102	CcSEcCtD
Desloratadine—Anorexia—Hydrocortisone—psoriasis	0.000258	0.00102	CcSEcCtD
Desloratadine—Diarrhoea—Mycophenolic acid—psoriasis	0.000257	0.00102	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000256	0.00102	CcSEcCtD
Desloratadine—Oedema—Triamcinolone—psoriasis	0.000254	0.00101	CcSEcCtD
Desloratadine—Anaphylactic shock—Triamcinolone—psoriasis	0.000254	0.00101	CcSEcCtD
Desloratadine—Infection—Triamcinolone—psoriasis	0.000253	0.001	CcSEcCtD
Desloratadine—Insomnia—Prednisolone—psoriasis	0.00025	0.000993	CcSEcCtD
Desloratadine—Hepatobiliary disease—Methotrexate—psoriasis	0.000249	0.000989	CcSEcCtD
Desloratadine—Gastrointestinal pain—Cyclosporine—psoriasis	0.000249	0.000987	CcSEcCtD
Desloratadine—Dizziness—Mycophenolic acid—psoriasis	0.000249	0.000987	CcSEcCtD
Desloratadine—Epistaxis—Methotrexate—psoriasis	0.000249	0.000986	CcSEcCtD
Desloratadine—Tachycardia—Triamcinolone—psoriasis	0.000248	0.000986	CcSEcCtD
Desloratadine—Mental disorder—Prednisone—psoriasis	0.000248	0.000984	CcSEcCtD
Desloratadine—Erythema—Prednisone—psoriasis	0.000246	0.000978	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000246	0.000977	CcSEcCtD
Desloratadine—Convulsion—Dexamethasone—psoriasis	0.000245	0.000973	CcSEcCtD
Desloratadine—Convulsion—Betamethasone—psoriasis	0.000245	0.000973	CcSEcCtD
Desloratadine—Insomnia—Hydrocortisone—psoriasis	0.000244	0.00097	CcSEcCtD
Desloratadine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000243	0.0144	CbGpPWpGaD
Desloratadine—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000243	0.000963	CcSEcCtD
Desloratadine—Urticaria—Cyclosporine—psoriasis	0.000242	0.000959	CcSEcCtD
Desloratadine—Myalgia—Betamethasone—psoriasis	0.000241	0.000956	CcSEcCtD
Desloratadine—Myalgia—Dexamethasone—psoriasis	0.000241	0.000956	CcSEcCtD
Desloratadine—Body temperature increased—Cyclosporine—psoriasis	0.00024	0.000954	CcSEcCtD
Desloratadine—Abdominal pain—Cyclosporine—psoriasis	0.00024	0.000954	CcSEcCtD
Desloratadine—Vomiting—Mycophenolic acid—psoriasis	0.000239	0.000949	CcSEcCtD
Desloratadine—Dyspepsia—Hydrocortisone—psoriasis	0.000238	0.000944	CcSEcCtD
Desloratadine—Rash—Mycophenolic acid—psoriasis	0.000237	0.000941	CcSEcCtD
Desloratadine—Dermatitis—Mycophenolic acid—psoriasis	0.000237	0.00094	CcSEcCtD
Desloratadine—Hepatitis—Methotrexate—psoriasis	0.000237	0.000939	CcSEcCtD
Desloratadine—Urticaria—Mycophenolate mofetil—psoriasis	0.000236	0.000935	CcSEcCtD
Desloratadine—Headache—Mycophenolic acid—psoriasis	0.000235	0.000935	CcSEcCtD
Desloratadine—Decreased appetite—Hydrocortisone—psoriasis	0.000235	0.000933	CcSEcCtD
Desloratadine—Pharyngitis—Methotrexate—psoriasis	0.000235	0.000932	CcSEcCtD
Desloratadine—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000235	0.000931	CcSEcCtD
Desloratadine—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000235	0.000931	CcSEcCtD
Desloratadine—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000234	0.0139	CbGpPWpGaD
Desloratadine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000233	0.0139	CbGpPWpGaD
Desloratadine—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000233	0.000926	CcSEcCtD
Desloratadine—Fatigue—Hydrocortisone—psoriasis	0.000233	0.000925	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000232	0.00092	CcSEcCtD
Desloratadine—Oedema—Betamethasone—psoriasis	0.000231	0.000917	CcSEcCtD
Desloratadine—Anaphylactic shock—Betamethasone—psoriasis	0.000231	0.000917	CcSEcCtD
Desloratadine—Anaphylactic shock—Dexamethasone—psoriasis	0.000231	0.000917	CcSEcCtD
Desloratadine—Oedema—Dexamethasone—psoriasis	0.000231	0.000917	CcSEcCtD
Desloratadine—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00023	0.0137	CbGpPWpGaD
Desloratadine—Insomnia—Triamcinolone—psoriasis	0.00023	0.000914	CcSEcCtD
Desloratadine—Infection—Dexamethasone—psoriasis	0.000229	0.000911	CcSEcCtD
Desloratadine—Infection—Betamethasone—psoriasis	0.000229	0.000911	CcSEcCtD
Desloratadine—Dyspnoea—Triamcinolone—psoriasis	0.000227	0.000901	CcSEcCtD
Desloratadine—Nervous system disorder—Betamethasone—psoriasis	0.000226	0.000899	CcSEcCtD
Desloratadine—Nervous system disorder—Dexamethasone—psoriasis	0.000226	0.000899	CcSEcCtD
Desloratadine—Agitation—Prednisone—psoriasis	0.000226	0.000899	CcSEcCtD
Desloratadine—Tachycardia—Betamethasone—psoriasis	0.000225	0.000894	CcSEcCtD
Desloratadine—Tachycardia—Dexamethasone—psoriasis	0.000225	0.000894	CcSEcCtD
Desloratadine—Angioedema—Prednisone—psoriasis	0.000225	0.000894	CcSEcCtD
Desloratadine—Hypersensitivity—Cyclosporine—psoriasis	0.000224	0.000889	CcSEcCtD
Desloratadine—Dyspepsia—Triamcinolone—psoriasis	0.000224	0.000889	CcSEcCtD
Desloratadine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000223	0.0133	CbGpPWpGaD
Desloratadine—Nausea—Mycophenolic acid—psoriasis	0.000223	0.000886	CcSEcCtD
Desloratadine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000221	0.0132	CbGpPWpGaD
Desloratadine—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000221	0.000877	CcSEcCtD
Desloratadine—Anorexia—Dexamethasone—psoriasis	0.00022	0.000874	CcSEcCtD
Desloratadine—Anorexia—Betamethasone—psoriasis	0.00022	0.000874	CcSEcCtD
Desloratadine—Urticaria—Prednisolone—psoriasis	0.00022	0.000873	CcSEcCtD
Desloratadine—Cardiac disorder—Methotrexate—psoriasis	0.00022	0.000871	CcSEcCtD
Desloratadine—Fatigue—Triamcinolone—psoriasis	0.000219	0.000871	CcSEcCtD
Desloratadine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000219	0.000868	CcSEcCtD
Desloratadine—Asthenia—Cyclosporine—psoriasis	0.000218	0.000866	CcSEcCtD
Desloratadine—Pruritus—Cyclosporine—psoriasis	0.000215	0.000854	CcSEcCtD
Desloratadine—Urticaria—Hydrocortisone—psoriasis	0.000215	0.000852	CcSEcCtD
Desloratadine—Body temperature increased—Hydrocortisone—psoriasis	0.000214	0.000848	CcSEcCtD
Desloratadine—Abdominal pain—Hydrocortisone—psoriasis	0.000214	0.000848	CcSEcCtD
Desloratadine—Convulsion—Prednisone—psoriasis	0.000213	0.000847	CcSEcCtD
Desloratadine—Asthenia—Mycophenolate mofetil—psoriasis	0.000213	0.000845	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Betamethasone—psoriasis	0.00021	0.000835	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.00021	0.000835	CcSEcCtD
Desloratadine—Pruritus—Mycophenolate mofetil—psoriasis	0.00021	0.000833	CcSEcCtD
Desloratadine—Myalgia—Prednisone—psoriasis	0.00021	0.000833	CcSEcCtD
Desloratadine—Insomnia—Dexamethasone—psoriasis	0.000209	0.000829	CcSEcCtD
Desloratadine—Insomnia—Betamethasone—psoriasis	0.000209	0.000829	CcSEcCtD
Desloratadine—Diarrhoea—Cyclosporine—psoriasis	0.000208	0.000826	CcSEcCtD
Desloratadine—Mental disorder—Methotrexate—psoriasis	0.000207	0.000823	CcSEcCtD
Desloratadine—Erythema—Methotrexate—psoriasis	0.000206	0.000817	CcSEcCtD
Desloratadine—Hypersensitivity—Prednisolone—psoriasis	0.000204	0.000809	CcSEcCtD
Desloratadine—Dyspepsia—Betamethasone—psoriasis	0.000203	0.000807	CcSEcCtD
Desloratadine—Dyspepsia—Dexamethasone—psoriasis	0.000203	0.000807	CcSEcCtD
Desloratadine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000203	0.000806	CcSEcCtD
Desloratadine—Urticaria—Triamcinolone—psoriasis	0.000202	0.000802	CcSEcCtD
Desloratadine—Body temperature increased—Triamcinolone—psoriasis	0.000201	0.000798	CcSEcCtD
Desloratadine—Dizziness—Cyclosporine—psoriasis	0.000201	0.000798	CcSEcCtD
Desloratadine—Oedema—Prednisone—psoriasis	0.000201	0.000798	CcSEcCtD
Desloratadine—Anaphylactic shock—Prednisone—psoriasis	0.000201	0.000798	CcSEcCtD
Desloratadine—Decreased appetite—Dexamethasone—psoriasis	0.000201	0.000797	CcSEcCtD
Desloratadine—Decreased appetite—Betamethasone—psoriasis	0.000201	0.000797	CcSEcCtD
Desloratadine—Infection—Prednisone—psoriasis	0.0002	0.000793	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Betamethasone—psoriasis	0.000199	0.000791	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000199	0.000791	CcSEcCtD
Desloratadine—Hypersensitivity—Hydrocortisone—psoriasis	0.000199	0.00079	CcSEcCtD
Desloratadine—Fatigue—Betamethasone—psoriasis	0.000199	0.00079	CcSEcCtD
Desloratadine—Fatigue—Dexamethasone—psoriasis	0.000199	0.00079	CcSEcCtD
Desloratadine—Nervous system disorder—Prednisone—psoriasis	0.000197	0.000783	CcSEcCtD
Desloratadine—Tachycardia—Prednisone—psoriasis	0.000196	0.000779	CcSEcCtD
Desloratadine—Dizziness—Mycophenolate mofetil—psoriasis	0.000196	0.000779	CcSEcCtD
Desloratadine—Asthenia—Hydrocortisone—psoriasis	0.000194	0.00077	CcSEcCtD
Desloratadine—Vomiting—Cyclosporine—psoriasis	0.000193	0.000767	CcSEcCtD
Desloratadine—Rash—Cyclosporine—psoriasis	0.000192	0.000761	CcSEcCtD
Desloratadine—Anorexia—Prednisone—psoriasis	0.000192	0.000761	CcSEcCtD
Desloratadine—Dermatitis—Cyclosporine—psoriasis	0.000192	0.00076	CcSEcCtD
Desloratadine—Pruritus—Hydrocortisone—psoriasis	0.000191	0.000759	CcSEcCtD
Desloratadine—Headache—Cyclosporine—psoriasis	0.000191	0.000756	CcSEcCtD
Desloratadine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000189	0.0112	CbGpPWpGaD
Desloratadine—Gastrointestinal pain—Betamethasone—psoriasis	0.000189	0.000749	CcSEcCtD
Desloratadine—Gastrointestinal pain—Dexamethasone—psoriasis	0.000189	0.000749	CcSEcCtD
Desloratadine—Vomiting—Mycophenolate mofetil—psoriasis	0.000189	0.000749	CcSEcCtD
Desloratadine—Hypersensitivity—Triamcinolone—psoriasis	0.000187	0.000744	CcSEcCtD
Desloratadine—Rash—Mycophenolate mofetil—psoriasis	0.000187	0.000742	CcSEcCtD
Desloratadine—Dermatitis—Mycophenolate mofetil—psoriasis	0.000187	0.000742	CcSEcCtD
Desloratadine—Headache—Mycophenolate mofetil—psoriasis	0.000186	0.000738	CcSEcCtD
Desloratadine—Diarrhoea—Hydrocortisone—psoriasis	0.000185	0.000734	CcSEcCtD
Desloratadine—Urticaria—Betamethasone—psoriasis	0.000183	0.000728	CcSEcCtD
Desloratadine—Urticaria—Dexamethasone—psoriasis	0.000183	0.000728	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Prednisone—psoriasis	0.000183	0.000727	CcSEcCtD
Desloratadine—Dizziness—Prednisolone—psoriasis	0.000183	0.000726	CcSEcCtD
Desloratadine—Asthenia—Triamcinolone—psoriasis	0.000183	0.000725	CcSEcCtD
Desloratadine—Abdominal pain—Dexamethasone—psoriasis	0.000183	0.000725	CcSEcCtD
Desloratadine—Abdominal pain—Betamethasone—psoriasis	0.000183	0.000725	CcSEcCtD
Desloratadine—Body temperature increased—Betamethasone—psoriasis	0.000183	0.000725	CcSEcCtD
Desloratadine—Body temperature increased—Dexamethasone—psoriasis	0.000183	0.000725	CcSEcCtD
Desloratadine—Insomnia—Prednisone—psoriasis	0.000182	0.000722	CcSEcCtD
Desloratadine—Nausea—Cyclosporine—psoriasis	0.000181	0.000717	CcSEcCtD
Desloratadine—Pruritus—Triamcinolone—psoriasis	0.00018	0.000715	CcSEcCtD
Desloratadine—Cough—Methotrexate—psoriasis	0.00018	0.000713	CcSEcCtD
Desloratadine—Dizziness—Hydrocortisone—psoriasis	0.000179	0.000709	CcSEcCtD
Desloratadine—Convulsion—Methotrexate—psoriasis	0.000178	0.000708	CcSEcCtD
Desloratadine—Dyspepsia—Prednisone—psoriasis	0.000177	0.000703	CcSEcCtD
Desloratadine—Nausea—Mycophenolate mofetil—psoriasis	0.000176	0.000699	CcSEcCtD
Desloratadine—Myalgia—Methotrexate—psoriasis	0.000175	0.000696	CcSEcCtD
Desloratadine—Decreased appetite—Prednisone—psoriasis	0.000175	0.000694	CcSEcCtD
Desloratadine—Rash—Prednisolone—psoriasis	0.000174	0.000693	CcSEcCtD
Desloratadine—Dermatitis—Prednisolone—psoriasis	0.000174	0.000692	CcSEcCtD
Desloratadine—Fatigue—Prednisone—psoriasis	0.000173	0.000688	CcSEcCtD
Desloratadine—Headache—Prednisolone—psoriasis	0.000173	0.000688	CcSEcCtD
Desloratadine—Vomiting—Hydrocortisone—psoriasis	0.000172	0.000682	CcSEcCtD
Desloratadine—Rash—Hydrocortisone—psoriasis	0.00017	0.000676	CcSEcCtD
Desloratadine—Dermatitis—Hydrocortisone—psoriasis	0.00017	0.000676	CcSEcCtD
Desloratadine—Headache—Hydrocortisone—psoriasis	0.000169	0.000672	CcSEcCtD
Desloratadine—Dizziness—Triamcinolone—psoriasis	0.000168	0.000668	CcSEcCtD
Desloratadine—Anaphylactic shock—Methotrexate—psoriasis	0.000168	0.000667	CcSEcCtD
Desloratadine—Infection—Methotrexate—psoriasis	0.000167	0.000663	CcSEcCtD
Desloratadine—Asthenia—Dexamethasone—psoriasis	0.000166	0.000658	CcSEcCtD
Desloratadine—Asthenia—Betamethasone—psoriasis	0.000166	0.000658	CcSEcCtD
Desloratadine—Nervous system disorder—Methotrexate—psoriasis	0.000165	0.000654	CcSEcCtD
Desloratadine—Gastrointestinal pain—Prednisone—psoriasis	0.000164	0.000653	CcSEcCtD
Desloratadine—Nausea—Prednisolone—psoriasis	0.000164	0.000652	CcSEcCtD
Desloratadine—Pruritus—Betamethasone—psoriasis	0.000163	0.000648	CcSEcCtD
Desloratadine—Pruritus—Dexamethasone—psoriasis	0.000163	0.000648	CcSEcCtD
Desloratadine—Vomiting—Triamcinolone—psoriasis	0.000162	0.000642	CcSEcCtD
Desloratadine—Nausea—Hydrocortisone—psoriasis	0.000161	0.000637	CcSEcCtD
Desloratadine—Rash—Triamcinolone—psoriasis	0.00016	0.000637	CcSEcCtD
Desloratadine—Dermatitis—Triamcinolone—psoriasis	0.00016	0.000636	CcSEcCtD
Desloratadine—Anorexia—Methotrexate—psoriasis	0.00016	0.000636	CcSEcCtD
Desloratadine—Urticaria—Prednisone—psoriasis	0.00016	0.000634	CcSEcCtD
Desloratadine—HRH1—IL-4 Signaling Pathway—SOCS1—psoriasis	0.00016	0.00948	CbGpPWpGaD
Desloratadine—Headache—Triamcinolone—psoriasis	0.000159	0.000633	CcSEcCtD
Desloratadine—Abdominal pain—Prednisone—psoriasis	0.000159	0.000631	CcSEcCtD
Desloratadine—Body temperature increased—Prednisone—psoriasis	0.000159	0.000631	CcSEcCtD
Desloratadine—Diarrhoea—Betamethasone—psoriasis	0.000158	0.000627	CcSEcCtD
Desloratadine—Diarrhoea—Dexamethasone—psoriasis	0.000158	0.000627	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000153	0.000608	CcSEcCtD
Desloratadine—Dizziness—Dexamethasone—psoriasis	0.000153	0.000606	CcSEcCtD
Desloratadine—Dizziness—Betamethasone—psoriasis	0.000153	0.000606	CcSEcCtD
Desloratadine—Insomnia—Methotrexate—psoriasis	0.000152	0.000603	CcSEcCtD
Desloratadine—Nausea—Triamcinolone—psoriasis	0.000151	0.0006	CcSEcCtD
Desloratadine—Dyspnoea—Methotrexate—psoriasis	0.00015	0.000595	CcSEcCtD
Desloratadine—Somnolence—Methotrexate—psoriasis	0.000149	0.000593	CcSEcCtD
Desloratadine—Hypersensitivity—Prednisone—psoriasis	0.000148	0.000588	CcSEcCtD
Desloratadine—Dyspepsia—Methotrexate—psoriasis	0.000148	0.000587	CcSEcCtD
Desloratadine—Vomiting—Dexamethasone—psoriasis	0.000147	0.000583	CcSEcCtD
Desloratadine—Vomiting—Betamethasone—psoriasis	0.000147	0.000583	CcSEcCtD
Desloratadine—Decreased appetite—Methotrexate—psoriasis	0.000146	0.00058	CcSEcCtD
Desloratadine—Rash—Dexamethasone—psoriasis	0.000146	0.000578	CcSEcCtD
Desloratadine—Rash—Betamethasone—psoriasis	0.000146	0.000578	CcSEcCtD
Desloratadine—Dermatitis—Dexamethasone—psoriasis	0.000145	0.000577	CcSEcCtD
Desloratadine—Dermatitis—Betamethasone—psoriasis	0.000145	0.000577	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Methotrexate—psoriasis	0.000145	0.000576	CcSEcCtD
Desloratadine—Fatigue—Methotrexate—psoriasis	0.000145	0.000575	CcSEcCtD
Desloratadine—Headache—Dexamethasone—psoriasis	0.000145	0.000574	CcSEcCtD
Desloratadine—Headache—Betamethasone—psoriasis	0.000145	0.000574	CcSEcCtD
Desloratadine—Asthenia—Prednisone—psoriasis	0.000144	0.000573	CcSEcCtD
Desloratadine—Pruritus—Prednisone—psoriasis	0.000142	0.000565	CcSEcCtD
Desloratadine—HRH1—IL-4 Signaling Pathway—IL4—psoriasis	0.000139	0.00827	CbGpPWpGaD
Desloratadine—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.000139	0.00824	CbGpPWpGaD
Desloratadine—Diarrhoea—Prednisone—psoriasis	0.000138	0.000546	CcSEcCtD
Desloratadine—Gastrointestinal pain—Methotrexate—psoriasis	0.000137	0.000545	CcSEcCtD
Desloratadine—Nausea—Betamethasone—psoriasis	0.000137	0.000544	CcSEcCtD
Desloratadine—Nausea—Dexamethasone—psoriasis	0.000137	0.000544	CcSEcCtD
Desloratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.000137	0.00813	CbGpPWpGaD
Desloratadine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000134	0.00798	CbGpPWpGaD
Desloratadine—Urticaria—Methotrexate—psoriasis	0.000134	0.00053	CcSEcCtD
Desloratadine—Dizziness—Prednisone—psoriasis	0.000133	0.000528	CcSEcCtD
Desloratadine—Abdominal pain—Methotrexate—psoriasis	0.000133	0.000527	CcSEcCtD
Desloratadine—Body temperature increased—Methotrexate—psoriasis	0.000133	0.000527	CcSEcCtD
Desloratadine—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000129	0.00766	CbGpPWpGaD
Desloratadine—Vomiting—Prednisone—psoriasis	0.000128	0.000507	CcSEcCtD
Desloratadine—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.000127	0.00756	CbGpPWpGaD
Desloratadine—Rash—Prednisone—psoriasis	0.000127	0.000503	CcSEcCtD
Desloratadine—Dermatitis—Prednisone—psoriasis	0.000127	0.000503	CcSEcCtD
Desloratadine—Headache—Prednisone—psoriasis	0.000126	0.0005	CcSEcCtD
Desloratadine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000125	0.00745	CbGpPWpGaD
Desloratadine—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000125	0.00743	CbGpPWpGaD
Desloratadine—Hypersensitivity—Methotrexate—psoriasis	0.000124	0.000491	CcSEcCtD
Desloratadine—Asthenia—Methotrexate—psoriasis	0.000121	0.000479	CcSEcCtD
Desloratadine—Nausea—Prednisone—psoriasis	0.000119	0.000474	CcSEcCtD
Desloratadine—Pruritus—Methotrexate—psoriasis	0.000119	0.000472	CcSEcCtD
Desloratadine—CYP2D6—Biological oxidations—CYP2S1—psoriasis	0.000119	0.00705	CbGpPWpGaD
Desloratadine—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000118	0.00699	CbGpPWpGaD
Desloratadine—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	0.000117	0.00695	CbGpPWpGaD
Desloratadine—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000116	0.00689	CbGpPWpGaD
Desloratadine—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	0.000115	0.00683	CbGpPWpGaD
Desloratadine—Diarrhoea—Methotrexate—psoriasis	0.000115	0.000456	CcSEcCtD
Desloratadine—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	0.000114	0.0068	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000112	0.00665	CbGpPWpGaD
Desloratadine—Dizziness—Methotrexate—psoriasis	0.000111	0.000441	CcSEcCtD
Desloratadine—HRH1—IL-4 Signaling Pathway—NFKBIA—psoriasis	0.00011	0.00652	CbGpPWpGaD
Desloratadine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000107	0.00637	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.000107	0.00636	CbGpPWpGaD
Desloratadine—Vomiting—Methotrexate—psoriasis	0.000107	0.000424	CcSEcCtD
Desloratadine—ABCB1—Allograft Rejection—IL13—psoriasis	0.000106	0.00632	CbGpPWpGaD
Desloratadine—Rash—Methotrexate—psoriasis	0.000106	0.000421	CcSEcCtD
Desloratadine—Dermatitis—Methotrexate—psoriasis	0.000106	0.00042	CcSEcCtD
Desloratadine—Headache—Methotrexate—psoriasis	0.000105	0.000418	CcSEcCtD
Desloratadine—HRH1—GPCR ligand binding—HCAR2—psoriasis	0.000104	0.00619	CbGpPWpGaD
Desloratadine—CYP1A2—Biological oxidations—CYP2S1—psoriasis	0.0001	0.00597	CbGpPWpGaD
Desloratadine—Nausea—Methotrexate—psoriasis	9.98e-05	0.000396	CcSEcCtD
Desloratadine—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	9.91e-05	0.00589	CbGpPWpGaD
Desloratadine—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	9.89e-05	0.00588	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—IL17A—psoriasis	9.79e-05	0.00582	CbGpPWpGaD
Desloratadine—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	9.74e-05	0.00579	CbGpPWpGaD
Desloratadine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.36e-05	0.00556	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—IL12B—psoriasis	9.1e-05	0.00541	CbGpPWpGaD
Desloratadine—HRH1—IL-4 Signaling Pathway—TYK2—psoriasis	8.99e-05	0.00534	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—HLA-E—psoriasis	8.88e-05	0.00528	CbGpPWpGaD
Desloratadine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.75e-05	0.0052	CbGpPWpGaD
Desloratadine—CYP1A2—Tryptophan metabolism—CAT—psoriasis	8.67e-05	0.00515	CbGpPWpGaD
Desloratadine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	7.47e-05	0.00444	CbGpPWpGaD
Desloratadine—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	7.44e-05	0.00442	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	7.35e-05	0.00437	CbGpPWpGaD
Desloratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	7.1e-05	0.00422	CbGpPWpGaD
Desloratadine—HRH1—IL-4 Signaling Pathway—NFKB1—psoriasis	7e-05	0.00416	CbGpPWpGaD
Desloratadine—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	6.84e-05	0.00406	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—IL10—psoriasis	6.65e-05	0.00395	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—IL4—psoriasis	6.47e-05	0.00385	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—HLA-B—psoriasis	6.33e-05	0.00376	CbGpPWpGaD
Desloratadine—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	6.32e-05	0.00376	CbGpPWpGaD
Desloratadine—HRH1—IL-4 Signaling Pathway—STAT3—psoriasis	6.29e-05	0.00374	CbGpPWpGaD
Desloratadine—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	5.89e-05	0.0035	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—HCAR2—psoriasis	5.89e-05	0.0035	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—HLA-A—psoriasis	5.86e-05	0.00348	CbGpPWpGaD
Desloratadine—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	5.79e-05	0.00344	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—CCL20—psoriasis	5.41e-05	0.00321	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	5.36e-05	0.00318	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—HCAR2—psoriasis	5.34e-05	0.00318	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	4.81e-05	0.00286	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	4.16e-05	0.00247	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	4.01e-05	0.00238	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—IFNG—psoriasis	3.91e-05	0.00232	CbGpPWpGaD
Desloratadine—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	3.91e-05	0.00232	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.64e-05	0.00216	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	3.64e-05	0.00216	CbGpPWpGaD
Desloratadine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.41e-05	0.00203	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HCAR2—psoriasis	3.16e-05	0.00188	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	3.12e-05	0.00185	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	3.12e-05	0.00185	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—CCL20—psoriasis	3.06e-05	0.00182	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	3e-05	0.00178	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	2.98e-05	0.00177	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.96e-05	0.00176	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—CCL20—psoriasis	2.78e-05	0.00165	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TAGAP—psoriasis	2.74e-05	0.00163	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—NDUFA5—psoriasis	2.59e-05	0.00154	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—TNF—psoriasis	2.53e-05	0.0015	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—NDUFA5—psoriasis	2.53e-05	0.0015	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.52e-05	0.0015	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.42e-05	0.00144	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—NDUFA5—psoriasis	2.39e-05	0.00142	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NDUFA5—psoriasis	2.37e-05	0.00141	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.35e-05	0.0014	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.24e-05	0.00133	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYP2S1—psoriasis	2.21e-05	0.00131	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.21e-05	0.00131	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP2S1—psoriasis	2.15e-05	0.00128	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP2S1—psoriasis	2.03e-05	0.00121	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NDUFA5—psoriasis	2.02e-05	0.0012	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP2S1—psoriasis	2.01e-05	0.00119	CbGpPWpGaD
Desloratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.92e-05	0.00114	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.88e-05	0.00112	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP2S1—psoriasis	1.72e-05	0.00102	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.67e-05	0.000992	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CCL20—psoriasis	1.64e-05	0.000974	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.61e-05	0.000955	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—CXCL8—psoriasis	1.46e-05	0.000868	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.46e-05	0.000866	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	1.46e-05	0.000865	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.25e-05	0.000743	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.16e-05	0.000687	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.1e-05	0.000655	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CARM1—psoriasis	1.08e-05	0.00064	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.05e-05	0.000626	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CARM1—psoriasis	1.05e-05	0.000625	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.01e-05	0.000598	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CARM1—psoriasis	9.91e-06	0.000589	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CARM1—psoriasis	9.82e-06	0.000584	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.18e-06	0.000545	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—SOCS1—psoriasis	9.03e-06	0.000537	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.01e-06	0.000535	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—TYK2—psoriasis	8.61e-06	0.000512	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CARM1—psoriasis	8.39e-06	0.000499	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—CXCL8—psoriasis	8.26e-06	0.000491	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.85e-06	0.000466	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—CXCL8—psoriasis	7.5e-06	0.000445	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—LEP—psoriasis	6.66e-06	0.000396	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—APOE—psoriasis	6.66e-06	0.000396	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CAT—psoriasis	6.63e-06	0.000394	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CAT—psoriasis	6.47e-06	0.000384	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NFKBIA—psoriasis	6.21e-06	0.000369	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CAT—psoriasis	6.09e-06	0.000362	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CAT—psoriasis	6.04e-06	0.000359	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CAT—psoriasis	5.16e-06	0.000307	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—APOE—psoriasis	5.15e-06	0.000306	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TYK2—psoriasis	5.09e-06	0.000302	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—APOE—psoriasis	5.02e-06	0.000299	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—APOE—psoriasis	4.74e-06	0.000281	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—APOE—psoriasis	4.69e-06	0.000279	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PPARG—psoriasis	4.48e-06	0.000266	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CXCL8—psoriasis	4.43e-06	0.000263	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PPARG—psoriasis	4.38e-06	0.00026	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—IL6—psoriasis	4.21e-06	0.00025	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PPARG—psoriasis	4.12e-06	0.000245	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—JUN—psoriasis	4.12e-06	0.000245	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PPARG—psoriasis	4.09e-06	0.000243	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—APOE—psoriasis	4.01e-06	0.000238	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NFKB1—psoriasis	3.96e-06	0.000235	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—VEGFA—psoriasis	3.6e-06	0.000214	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—STAT3—psoriasis	3.56e-06	0.000212	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PPARG—psoriasis	3.49e-06	0.000208	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TP53—psoriasis	2.72e-06	0.000161	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IL6—psoriasis	2.49e-06	0.000148	CbGpPWpGaD
